A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
NCT05939128 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 625
Last updated 2026-05-15
Summary
(Neo)adjuvant treatment approaches and outcomes
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-30
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
Countries
- Russia
Study Locations
More Related Trials
-
Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma
NCT04365790 ·Status: UNKNOWN
-
Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
NCT05923177 ·Status: COMPLETED ·Phase: PHASE1
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02997384 ·Status: UNKNOWN
-
Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study
NCT04474834 ·Status: ACTIVE_NOT_RECRUITING
-
Korean Hereditary Breast Cancer Study
NCT00595348 ·Status: UNKNOWN
-
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery
NCT05914792 ·Status: ACTIVE_NOT_RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT06635980 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT01459003 ·Status: COMPLETED ·Phase: PHASE3
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 ·Status: COMPLETED
-
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT06833502 ·Status: RECRUITING ·Phase: PHASE2
-
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448 ·Status: ACTIVE_NOT_RECRUITING
-
Women At Risk: The High Risk Breast Cancer Program
NCT01034891 ·Status: UNKNOWN
-
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 ·Status: RECRUITING
-
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
NCT05034393 ·Status: COMPLETED
-
BRCA Mutations in Latinas
NCT01251900 ·Status: COMPLETED
-
National Survey on Infiltrative Breast Cancer
NCT00696527 ·Status: COMPLETED
-
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma
NCT05339113 ·Status: UNKNOWN ·Phase: NA
-
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931 ·Status: COMPLETED
-
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NCT04960839 ·Status: RECRUITING ·Phase: NA
-
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
NCT07056205 ·Status: ENROLLING_BY_INVITATION
-
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.
NCT05203497 ·Status: COMPLETED ·Phase: PHASE1
-
What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol
NCT04359420 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI
NCT02306538 ·Status: ACTIVE_NOT_RECRUITING